On Invalid Date, Tempest Therapeutics (NASDAQ: TPST) reported Q4 2023 earnings per share (EPS) of -$0.34, up 46.03% year over year. Total Tempest Therapeutics earnings for the quarter were -$7.49 million. In the same quarter last year, Tempest Therapeutics's earnings per share (EPS) was -$0.63.
As of Q2 2024, Tempest Therapeutics's earnings has grown year over year. Tempest Therapeutics's earnings in the past year totalled -$29.49 million.
What is TPST's earnings date?
Tempest Therapeutics's earnings date is Invalid Date. Add TPST to your watchlist to be reminded of TPST's next earnings announcement.
What was TPST's revenue last quarter?
On Invalid Date, Tempest Therapeutics (NASDAQ: TPST) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Tempest Therapeutics's revenue was $0.00.
What was TPST's revenue growth in the past year?
As of Q2 2024, Tempest Therapeutics's revenue has grown null year over year. Tempest Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.